Course Overview

This three-module course presented by Dr. James Greenblatt presents a novel paradigm for the prevention of Alzheimer’s, as well as general cognitive decline. It examines the pathophysiology of neurodegenerative illness from a functional medicine and systems biology framework, focusing on biochemical abnormalities contributing to neuronal dysfunction that are modifiable at certain prodromal stages…and, accordingly, viable functional treatment targets. Research supporting the use
of low-dose lithium and other evidence-based nutritional interventions as part of a preventative approach will be objectively reviewed, and the mechanisms through which these interventions confer neuroprotection elucidated.

Finally, evidence-based recommendations for the use of low-dose lithium and other functional medicine treatments will be proffered, providing students with actionable information that can be incorporated into existing treatment protocols to maximize therapeutic – and cognitive – outcomes.


Learning Objectives


Upon completion of this course, students will be able to:

  • Describe one way in which high homocysteine is related to risk for Alzheimer’s
  • List three OPCs and describe how they may impact brain health
  • Explain what each of the letters in the ZEEBRA model stands for, as an approach to treating Alzheimer’s and cognitive decline

Course Outline

    1. Welcome & Learning Path

    2. Course Overview & Learning Objectives

    3. Faculty Bio

    1. Module 1 Overview

    2. Alzheimer’s Disease and Cognitive Decline-1

    3. ALZ_Cog Decline MODULE 1 HANDOUT

    1. Module 2 Overview

    2. Alzheimer’s Disease and Cognitive Decline-2

    3. ALZ_Cog Decline MODULE 2 HANDOUT

    1. Module 3 Overview

    2. Alzheimer’s Disease and Cognitive Decline-3

    3. ALZ_Cog Decline MODULE 3 HANDOUT

    1. ALZ_Cog Decline COURSE BIBLIOGRAPHY

    2. Hara.17. Evaluation of the Neuroprotective Potential of N-Acetylcysteine for prevention of cognitive aging and dementia

    3. Jayedi.18. Vitamin D status and risk of dementia and Alzheimer’s disease_a meta-analysis of dose-response

    4. Alam.17. Vitamin B12 offers neuronal cell protection by inhibiting Aβ-42 amyloid fibrillation

    5. Smith et al.18. Homocysteine and Dementia_An International Consensus Statement

    6. Small. 18. Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults

    7. Wang. 09. Consumption of Grape Seed Extract Prevents Amyloid-Beta Deposition and Attenuates Inflammation in Brain of Alzheimer's Mouse

    8. Greenblatt.19. Alzheimers redefined_nutritional lithium as the foundation for prevention

About this course

  • $255.00
  • 20 lessons
  • 2.5 hours of video content

A Glimpse into Alzheimer's Disease

The global burden of Alzheimer’s Disease, neurodegenerative disorders, and cognitive decline is massive. Every 65 seconds, someone is diagnosed with Alzheimer’s Disease; it is the 6th leading cause of death nationwide, and the only one amongst the top ten for which there is no cure. Despite extensive research, traditional medicine and treatments have come up short from curing this terrible disease. Attempts to find a viable pharmaceutical cure have, thus far, failed, and the tolls borne by victims and family members alike remain incalculable.

Research has confirmed Alzheimer’s to have a substantial prodrome; the biologic processes underlying progressive cognitive decline may in fact commence decades before symptoms begin to manifest. The discovery of a lengthy prodrome in Alzheimer’s and other dementias is cause for hope. A prodrome represents a window of opportunity, a chance to steer neurologic aging towards health, and to modify certain etiologic factors while they remain modifiable. Such factors are tools that can be wielded to potentially significant effect in a functional medicine model centered upon prevention.

                           

Course Faculty

James Greenblatt, MD

Founder, Chief Medical Officer

James Greenblatt, MD, is is a pioneer in functional and integrative psychiatry and a board-certified child and adult psychiatrist who has been treating patients since 1988. He serves as an Assistant Clinical Professor of Psychiatry at Tufts University School of Medicine and Dartmouth’s Geisel School of Medicine. An internationally recognized speaker on nutritional interventions in mental health, Dr. Greenblatt has authored seven books, including the best-sellers Finally Focused and Answers to Anorexia, as well as his latest, Functional & Integrative Medicine for Antidepressant Withdrawal. In 2019, Dr. Greenblatt founded Psychiatry Redefined, the leading educational platform designed to transform psychiatric care through integrative, personalized and evidence-based approaches to treatment. Psychiatry Redefined bridges critical knowledge gaps for mental health professionals, providing a new hope for mental health care.